Sign in
CompletedNo phase

PCV13 Effectiveness Study Against Hospitalised VT Pneumococcal CAP in Adults 60 Years and Older

Key facts

Who runs it
Pfizer
Where
Spain5 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
1,821 people enrolled
Started
12 Mar 2021
Ended
24 Mar 2024
Type of study
Observational
Treatments tested
  • Urine sample collection
  • Saliva collection
Record updated
11 June 2025

Who can take part

Age
60 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Age ≥60 years
  • Evidence of pneumonia within first 48 hours of hospital admission
  • Evidence of a personally signed and dated informed consent document indicating that the patient (or a legally acceptable representative) has been informed of all pertinent aspects of the study

Who cannot take part

  • Previously enrolled subjects readmitted ≤14 days after discharge for their study qualifying admission
  • Any patient who develops signs and symptoms of pneumonia after being hospitalized for ≥48 hours (either at current hospital, another transferring hospital, or a combination of these)
  • At the time of enrollment, pneumonia has been excluded as the diagnosis or another diagnosis confirmed

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Low interventional, prospective, multicentre, hospital-based study involving adults 60 years of age and older hospitalised with CAP at participating sites.

The group in the trial

  • All participants

    Treatment: Urine sample collection and Saliva collection

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Low Intervention Study of the Effectiveness Of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Against Vaccine Type Pneumococcal Hospitalised Community Acquired Pneumonia (CAP) in Adults 60 Years and Older Using A Test Negative Design Study in A Well-Defined Area of the South of Madrid Region
Record updated
11 June 2025